Related Experiment Video
Updated: Jun 10, 2025

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
Honey Targets Ribosome Biogenesis Components to Suppress the Growth of Human Pancreatic Cancer Cells
Aun Ali Bangash1,2, Sahir Sultan Alvi1,2, Muhammad Ali Bangash1,2
1South Texas Center of Excellence for Cancer Research, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX 78504, USA.
Abstract:
Pancreatic cancer (PanCa) is one of the deadliest cancers, with limited therapeutic response. Various molecular oncogenic events, including dysregulation of ribosome biogenesis, are linked to the induction, progression, and metastasis of PanCa. Thus, the discovery of new therapies suppressing these oncogenic events and ribosome biogenesis could be a novel therapeutic approach for the prevention and treatment of PanCa. The current study was designed to investigate the anti-cancer effect of honey against PanCa. Our results indicated that honey markedly inhibited the growth and invasive characteristics of pancreatic cancer cells by suppressing the mRNA expression and protein levels of key components of ribosome biogenesis, including RNA Pol-I subunits (RPA194 and RPA135) along with its transcriptional regulators, i.e., UBTF and c-Myc. Honey also induced nucleolar stress in PanCa cells by reducing the expression of various nucleolar proteins (NCL, FBL, and NPM). Honey-mediated regulation on ribosome biogenesis components and nucleolar organization-associated proteins significantly arrested the cell cycle in the G2M phase and induced apoptosis in PanCa cells. These results, for the first time, demonstrated that honey, being a natural remedy, has the potential to induce apoptosis and inhibit the growth and metastatic phenotypes of PanCa by targeting ribosome biogenesis.
Insights
Honey shows potential as a natural remedy against pancreatic cancer (PanCa). It inhibits PanCa cell growth and metastasis by targeting ribosome biogenesis and inducing apoptosis.
Area of Science:
- Oncology
- Molecular Biology
- Natural Products Research
Background:
- Pancreatic cancer (PanCa) is a highly lethal malignancy with limited treatment options.
- Dysregulation of ribosome biogenesis is implicated in PanCa development, progression, and metastasis.
- Targeting ribosome biogenesis presents a novel therapeutic strategy for PanCa.
Purpose of the Study:
- To investigate the anti-cancer effects of honey on pancreatic cancer cells.
- To explore honey's impact on ribosome biogenesis pathways in PanCa.
- To determine if honey can induce apoptosis and inhibit PanCa cell growth and invasion.
Main Methods:
- Investigated honey's effect on PanCa cell growth and invasion.
- Assessed mRNA and protein levels of ribosome biogenesis components (RNA Pol-I subunits, UBTF, c-Myc).
- Evaluated honey's impact on nucleolar proteins (NCL, FBL, NPM), cell cycle, and apoptosis.
Main Results:
- Honey significantly inhibited PanCa cell growth and invasion.
- Honey suppressed key ribosome biogenesis factors (RPA194, RPA135, UBTF, c-Myc) and nucleolar proteins.
- Honey induced nucleolar stress, G2M cell cycle arrest, and apoptosis in PanCa cells.
Conclusions:
- Honey demonstrates significant anti-cancer properties against pancreatic cancer.
- Honey effectively targets ribosome biogenesis and induces apoptosis in PanCa cells.
- Honey represents a promising natural therapeutic agent for PanCa treatment by modulating ribosome biogenesis.
More Related Videos
Related Concept Videos
Experimental RNAi
Targeted Cancer Therapies
There are several types of targeted therapies against...
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Nucleolus
Cell Specific Gene Expression

